News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALK-Abello A/S Announces An R&D And Business Briefing In NYC On 21 May


5/1/2014 9:22:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, 2014-05-01 16:00 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) will host an R&D and business briefing for the investment community on Wednesday, 21 May in New York City. The meeting offers an opportunity to learn more about allergy immunotherapy and will highlight the recent advances and future potential for ALK’s allergy immunotherapy business.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES